Description: A Phase 1 Study of KSQ-4279 Alone and in Combination in Patients with Advanced Solid Tumors.
Target Patient Population: Solid Tumors
Study Design: Study drug is given orally daily. Currently in monotherapy in dose escalation. Phase 2 will follow with expansion in combinations with mFOLFOX, Gem/Carbo and Olaparib combinations.